Business · 09/04/2025Updated: 10/17/2026 · 1 min read
Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 23 Abbreviated New Drug Applications; Correction
Summary
The FDA is correcting a notice that withdrew approval of 23 abbreviated new drug applications, including one for miglustat capsule, after a company objected to the withdrawal.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →